Checkpoint Therapeutics I... (CKPT)
undefined
undefined%
At close: undefined
3.52
-3.29%
After-hours Jan 03, 2025, 04:35 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue 103.00K 192.00K 268.00K 1.07M 1.71M 3.51M 1.73M 2.57M 590.00K
Cost of Revenue 43.57M 49.83M 48.45M 16.35M 19.32M 33.65M 19.08M 20.27M 11.32M
Gross Profit -43.46M -49.63M -48.19M -15.28M -17.62M -30.15M -17.36M -17.70M -10.73M
Operating Income -52.15M -58.33M -56.72M -23.20M -24.85M -36.74M -22.77M -22.16M -13.22M
Interest Income 84.00K 160.00K 53.00K 120.00K 136.00K 148.00K 98.00K 47.00K 2.00K
Pretax Income -51.85M -62.62M -56.67M -23.08M -24.71M -36.37M -22.68M -22.46M -13.89M
Net Income -51.85M -66.92M -56.62M -22.96M -24.58M -36.37M -22.68M -22.46M -13.89M
Selling & General & Admin 8.69M 8.70M 8.54M 7.92M 7.23M 6.59M 5.42M 4.47M 2.49M
Research & Development 43.57M 49.83M 48.45M 16.35M 19.32M 33.65M 19.08M 20.27M 11.32M
Other Expenses n/a n/a n/a n/a n/a 225.00K n/a n/a n/a
Operating Expenses 52.25M 58.52M 56.99M 24.27M 26.56M 40.25M 24.50M 24.73M 13.81M
Interest Expense n/a 4.29M n/a n/a n/a n/a n/a 344.00K 235.00K
Selling & Marketing Expenses n/a 400.00K n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 52.25M 58.52M 56.99M 24.27M 26.56M 40.25M 24.50M 24.73M 13.81M
Income Tax n/a 4.29M -53.00K -120.00K -136.00K -521.00K -22.68M -22.12M 233.00K
Shares Outstanding (Basic) 18.74M 8.84M 7.60M 5.58M 3.53M 2.86M 2.26M 2.15M 2.44M
Shares Outstanding (Diluted) 18.74M 8.84M 7.60M 5.58M 3.53M 2.86M 2.26M 2.15M 2.44M
EPS (Basic) -2.77 -7.57 -7.45 -4.11 -6.96 -12.74 -10.03 -10.43 -5.69
EPS (Diluted) -2.77 -7.57 -7.45 -4.11 -6.96 -12.74 -10.03 -10.43 -5.69
EBITDA -52.15M -58.33M -56.72M -23.20M -24.85M -36.74M -22.68M -22.12M -13.22M
Depreciation & Amortization n/a 4.45M 236.56K 206.30K 171.86K 36.74M 22.77M 22.16M 2.00K